These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 2848629

  • 1. Combined treatment with interferon (IFN)-gamma and tumor necrosis factor (TNF)-alpha up-regulates the expression of HLA class I determinants in Burkitt lymphoma lines.
    Avila-Carino J, Torsteinsdottir S, Bejarano MT, Klein G, Klein E, Masucci MG.
    Cell Immunol; 1988 Dec; 117(2):303-11. PubMed ID: 2848629
    [Abstract] [Full Text] [Related]

  • 2. Down-regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma lines.
    Masucci MG, Torsteindottir S, Colombani J, Brautbar C, Klein E, Klein G.
    Proc Natl Acad Sci U S A; 1987 Jul; 84(13):4567-71. PubMed ID: 3037521
    [Abstract] [Full Text] [Related]

  • 3. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
    Rowe M, Khanna R, Jacob CA, Argaet V, Kelly A, Powis S, Belich M, Croom-Carter D, Lee S, Burrows SR.
    Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
    [Abstract] [Full Text] [Related]

  • 4. Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: in vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells.
    Masucci MG, Zhang QJ, Gavioli R, De Campos-Lima PO, Murray RJ, Brooks J, Griffin H, Ploegh H, Rickinson AB.
    Int Immunol; 1992 Nov; 4(11):1283-92. PubMed ID: 1282031
    [Abstract] [Full Text] [Related]

  • 5. Recognition of the Epstein-Barr virus-encoded nuclear antigens EBNA-4 and EBNA-6 by HLA-A11-restricted cytotoxic T lymphocytes: implications for down-regulation of HLA-A11 in Burkitt lymphoma.
    Gavioli R, De Campos-Lima PO, Kurilla MG, Kieff E, Klein G, Masucci MG.
    Proc Natl Acad Sci U S A; 1992 Jul 01; 89(13):5862-6. PubMed ID: 1321426
    [Abstract] [Full Text] [Related]

  • 6. Aberrant expression of HLA class-I antigens in Burkitt lymphoma cells.
    Andersson ML, Stam NJ, Klein G, Ploegh HL, Masucci MG.
    Int J Cancer; 1991 Feb 20; 47(4):544-50. PubMed ID: 1899854
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Restoration of the LFA-3 adhesion pathway in Burkitt's lymphoma cells using an LFA-3 recombinant vaccinia virus: consequences for T cell recognition.
    Griffin H, Rowe M, Murray R, Brooks J, Rickinson A.
    Eur J Immunol; 1992 Jul 20; 22(7):1741-8. PubMed ID: 1378014
    [Abstract] [Full Text] [Related]

  • 12. Mechanisms of allele-selective down-regulation of HLA class I in Burkitt's lymphoma.
    Imreh MP, Zhang QJ, de Campos-Lima PO, Imreh S, Krausa P, Browning M, Klein G, Masucci MG.
    Int J Cancer; 1995 Jul 04; 62(1):90-6. PubMed ID: 7601573
    [Abstract] [Full Text] [Related]

  • 13. Lymphotoxin acts as an autocrine growth factor for Epstein-Barr virus-transformed B cells and differentiated Burkitt lymphoma cell lines.
    Gibbons DL, Rowe M, Cope AP, Feldmann M, Brennan FM.
    Eur J Immunol; 1994 Aug 04; 24(8):1879-85. PubMed ID: 8056047
    [Abstract] [Full Text] [Related]

  • 14. Stimulation with allogeneic Epstein-Barr virus-transformed lymphoblastoid cell lines generates HLA class I-specific CTLs with different target cell avidity.
    Torsteinsdottir S, Cuomo L, Klein E, Masucci MG.
    Cell Immunol; 1991 Oct 15; 137(2):501-13. PubMed ID: 1654213
    [Abstract] [Full Text] [Related]

  • 15. Paired Epstein-Barr virus-carrying lymphoma and lymphoblastoid cell lines from Burkitt's lymphoma patients: comparative sensitivity to non-specific and to allo-specific cytotoxic responses in vitro.
    Rooney CM, Rickinson AB, Moss DJ, Lenoir GM, Epstein MA.
    Int J Cancer; 1984 Sep 15; 34(3):339-48. PubMed ID: 6090321
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A monoclonal antibody with anti-Burkitt lymphoma specificity. I. Analysis of human haematopoietic and lymphoid cell lines.
    Wiels J, Lenoir GM, Fellous M, Lipinski M, Salomon JC, Tetaud C, Tursz T.
    Int J Cancer; 1982 Jun 15; 29(6):653-8. PubMed ID: 6286514
    [Abstract] [Full Text] [Related]

  • 20. Generation of HLA-B55 restricted T lymphocyte mediated cytotoxicity against autologous LCL.
    Avila-Cariño J, Végh Z, Klein E.
    Mol Immunol; 1994 Jan 15; 31(1):59-63. PubMed ID: 8302299
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.